Drug therapy in children and adolescents with severe bronchial asthma and/or severe atopic dermatitis
Recruiting
- Conditions
- J45L20AsthmaAtopic dermatitis
- Registration Number
- DRKS00028092
- Lead Sponsor
- niversität Leipzig
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Written consent of parents (or guardians) to participate in the study.
Diagnosis of a severe asthma and/or severe atopic dermatitis in paediatric patients
Sufficient ability to understand the questions asked
Sufficient communication skills
Exclusion Criteria
Refusal of participation by the patient or the parents (or guardians)
No signature of the consent form
No fulfilment of the other inclusion criteria
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Subjective assessment of pediatric patients and their caregivers on illness experience, drug adherence, and daily life changes.<br>2) Number of drug-related problems with drug administration, assessed via observation of drug demonstrations on a model.
- Secondary Outcome Measures
Name Time Method